Publication date: Sep 21, 2023
Portable assays for the rapid identification of lineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed to aid large-scale efforts in monitoring the evolution of the virus. Here we report a multiplexed assay in a microarray format for the detection, via isothermal amplification and plasmonic-gold-enhanced near-infrared fluorescence, of variants of SARS-CoV-2. The assay, which has single-nucleotide specificity for variant discrimination, single-RNA-copy sensitivity and does not require RNA extraction, discriminated 12 lineages of SARS-CoV-2 (in three mutational hotspots of the Spike protein) and detected the virus in nasopharyngeal swabs from 1,034 individuals at 98. 8% sensitivity and 100% specificity, with 97. 6% concordance with genome sequencing in variant discrimination. We also report a compact, portable and fully automated device integrating the entire swab-to-result workflow and amenable to the point-of-care detection of SARS-CoV-2 variants. Portable, rapid, accurate and multiplexed assays for the detection of SARS-CoV-2 variants and lineages may facilitate variant-surveillance efforts.
Concepts | Keywords |
---|---|
Biomed | Assays |
Coronavirus | Automated |
Fluorescence | Cov |
Workflow | Detection |
Device | |
Discrimination | |
Enhanced | |
Fluorescence | |
Lineages | |
Multiplexed | |
Plasmonic | |
Portable | |
Sars | |
Variant | |
Variants |
Semantics
Type | Source | Name |
---|---|---|
disease | VO | device |
disease | VO | Severe acute respiratory syndrome coronavirus 2 |
disease | VO | report |
disease | IDO | assay |
drug | DRUGBANK | Gold |